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Abstract
Background: This study investigates the barriers and facilitators of the use of antibiotics in acute respiratory tract
infections by general practitioners (GPs) in Germany.
Methods: A multidisciplinary team designed and pre-tested a written questionnaire addressing the topics
awareness of antimicrobial resistance (7 items), use of antibiotics (9 items), guidelines/sources of information (9 items)
and sociodemographic factors (7 items), using a five-point-Likert-scale (“never” to “very often”). The questionnaire
was mailed by postally to 987 GPs with registered practices in eastern Germany in May 2015.
Results: 34% (340/987) of the GPs responded to this survey. Most of the participants assumed a multifactorial origin
for the rise of multidrug resistant organisms. In addition, 70.2% (239/340) believed that their own prescribing behavior
influenced the drug-resistance situation in their area. GPs with longer work experience (> 25 years) assumed less
individual influence on drug resistance than their colleagues with less than 7 years experience as practicing physicians
(Odds Ratio [OR] 0.32, 95% Confidence Interval [CI] 0.17–0.62; P < 0.001). 99.1% (337/340) of participants were familiar
with the “delayed prescription” strategy to reduce antibiotic prescriptions. However, only 29.4% (74/340) answered that
they apply it “often” or “very often”. GPs working in rural areas were less likely than those working in urban areas to
apply delayed prescription.
Conclusion: The knowledge on factors causing antimicrobial resistance in bacteria is good among GPs in eastern
Germany. However measures to improve rational prescription are not widely implemented yet. Further efforts have to
be made in order to improve rational prescription of antibiotic among GPs. Nevertheless, there is a strong awareness of
antimicrobial resistance among the participating GPs.
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Background
Antimicrobial resistance (AMR) jeopardizes the achieve-
ments of modern medicine in Europe and worldwide
[1–3]. The consumption of antibiotics is an important
driver of AMR [4, 5]. Over the past decade the global
antibiotic use increased significantly [6]. In the human
sector the primary use of antibiotics in outpatient care is
found among general practitioners (GPs) [7, 8]. There is
a considerable difference in outpatient antibiotic use
worldwide, between European countries and within
countries [9–11]. Considering the use of antibiotics in
primary care in Europe, Germany is one of the countries
with a lower level of consumption of antibiotics [12, 13].
Nevertheless, it is striking that the proportion of reserve
antibiotics in Germany is high [11, 14]. In Germany, the
total consumption of antibiotics in human medicine is
about 800 tons per year. Approximately 600 tons of this
are used in outpatient care [15]. More than half of the
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antibiotics used in outpatient care are prescribed by GPs
in Germany [16, 17]. In GP practices, the majority of an-
tibiotics is prescribed for acute respiratory infections,
most of which are caused by a virus [16, 18]. In most
cases they do not require antimicrobial therapy [19–22].
In Germany, antimicrobial resistance is mainly a prob-
lem in hospital care and especially in intensive care units
[23]. German health care system is divided in primary
and secondary care, most people are covered by statu-
tory health insurance [24].
The present survey was carried out in the preparation
of a broader intervention study, called “Rational
antibiotic Use via information and communication”
(RAI-project, www.rai-projekt.de). The RAI-project pro-
motes rational antibiotic use in veterinary medicine, in
particular in pig farming, as well as in human medicine,
surgery and intensive care units, travel medicine, and
primary care, with a focus on eastern Germany [25].
The following barriers to rational antibiotic usage have
been identified from the scientific literature. But expla-
nations of the barriers to rational antibiotic use vary
widely in primary care. Some authors describe that un-
certainty about pathogenesis, heavy workflow and pa-
tient’s desire for an antibiotic therapy can lead to
increased prescription of antibiotics [26–28] as well as
knowledge and health literacy among the general popu-
lation [29]. This questionnaire survey was carried out to
examine whether the barriers identified in the literature
can also be found in the intervention area.
Methods
Survey development
A multidisciplinary team of the RAI study group devel-
oped a questionnaire comprised of 32 questions grouped
around the four issues: awareness of antimicrobial resist-
ance (7 items), use of antibiotics (9 items), guidelines/
sources of information (9 items) and socio-demographic
factors (7 items). The majority of the answers were in
tick-box format (see Additional file 1).
To identify factors influencing prescribing behavior of
antibiotics we conducted a literature review. Based on
these results, the questionnaire was developed. The
inquiry of the sociodemographic data (Q1-Q4), as well
as the questions Q8, Q9, Q12 and Q13 are founded on a
previous study conducted among GPs in Germany in
2007 [30].
The questionnaire was pretested among scientists at
the Friedrich-Schiller-University (Jena) and the Charité
(Berlin). In a second step, a pilot test was conducted
among 12 GPs (03/2015). After completing the question-
naire, participants were asked to explain the content of
each question in their own words to increase internal
validity. GPs who took part in the pilot test were not in-
cluded in the survey.
Recruitment and data collection
The revised questionnaire was then mailed postally to
roughly one third (987) of the GPs from the German fed-
eral states of Thuringia, Brandenburg and Berlin (2015/05).
In Berlin and Thuringia, pre-existing lists of all regis-
tered doctors could be used. In Brandenburg, a list was
made available by the Brandenburg Medical Association,
with doctors who had agreed to be contacted. Partici-
pants were randomly selected from the address lists. In
addition to the questionnaire, the letter was accompan-
ied by an addressed and prepaid envelope. The survey
was paper based.
Statistical analysis
Differences were tested by Chi-Squared test. A p-value
of 0.05 was interpreted as significantly different. For
each question, linear logistic regression analysis was
performed to estimate predictors for the answers. Socio-
demographic factors and a variable for subjective in-
volvement were used as predictors (see Table 1).
Table 1 Demographic characteristics of the participants
Parameter Responder
Gender, female in percent, n (%) 212 (62.4)
Mean age in years (SD) 51.9 (+/− 8.8)
Mean professional experience in years (SD) 16.7 (+/−10.8)
Medical specialist in percent, n (%)
General Medicine 288 (84.7)
Internal Medicine 34 (10)
None 5 (1.5)
Other 11 (3.2)
Population of the practice location, n (%)
< 5,000 56 (16.5)
5,000–19,000 92 (27.1)
20,000–99,000 89 (26.2)
> 100,000 103 (30.3)
Kind of practice, n (%)
Single practice 193 (56.8)
Joint Practice 113 (33.2)
Practice Communities 26 (7.6)
Patient visits per quartile in percent, n (%)
< 400 5 (1.5)
400–800 53 (15.6)
801–1,200 128 (37.6)
1,201–1,600 98 (28.8)
> 1,600 48 (14.1)
Contact with patients with MDRO, n (%)
Weekly or more often 67 (19.7)
Note. All listed parameters were predictors in the multivariable analysis. MDRO
multidrug-resistant organism
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Participants were classified as subjectively involved when
they responded to “How often do you have contact to
patients with multi-resistant organisms in daily work?”
with “weekly or more often”. All analyses were per-
formed using SPSS [IBM SPSS statistics, Somer, NY,
USA] and SAS [SAS Institute, Cary, NC, USA].
Results
The questionnaire was completed by 340 of 987 (34.4%)
GPs. The socio-demographic factors are described in
Table 1. Most of the participants were female (62.4%).
The mean age was 52 (range 33–78) years and the mean
work experience was 16.8 years.
Awareness of antimicrobial resistance
Most of the participants assumed a multifactorial gen-
esis of the rise of multidrug resistant organisms. 80.
9% (275/340) of the participants indicated infection
control in hospitals, 80.3% (273/340) the use of
antibiotics by GPs and 79.1% (261/340) the use of
antibiotics in livestock as the main drivers for drug-
resistance (multi selection).
The majority of participants (70.2%;239/340) believed
that their own prescribing behavior influenced the drug-
resistance situation in their area. GPs with longer work
experience (> 25 years) assumed less individual influence
on drug resistance than do their colleagues with less
than 7 years experience as practicing physicians
(Odds Ration [OR] 0.32, 95% Confidence Interval [CI]
0.17–0.62; P < 0.001).
Guidelines/source of information
Seven percent (23/340) of the participants stated that
there is a lack of good guidelines dealing with antibiotic
therapy in ambulatory care. Thirty-nine percent (133/
340) of the GPs indicated that they frequently use guide-
lines for antibiotic therapy. Family doctors under the age
of 40 made use of guidelines more often than did those
older than 60 (OR 3.97, 95%CI 1.32–11.91; P = 0.001). In
addition, the location of their place of work (urban vs.
rural) influenced the response to this question (Table 2).
Use of antibiotics
Forty-four percent (151/340) of the GPs stated that one
reason for prescribing an antibiotic without a strong in-
dication was that it was just before a weekend when the
Table 2 Results of the multivariable analysis
Questions Odds Ratio (95% CI)
Relevance of antimicrobial resistance for
daily work
(Answers: strong/medium vs. little/not at all)
Contacts to patients with MDRO
Monthly or less frequently Reference
Weekly or more frequently 5.65 (1.71–18.64)
Do you believe that your prescribing behavior
influences the drug resistant organism situation
in your area?
(Answer: yes vs. no or I don’t know)
Work experience
0–7 years Reference
8–14 years 0.91 (0.44–1-91)
14–25 years 0.44 (0.23–0.85)
> 25 years 0.32 (0.17–0.62)
Do you use guidelines in your daily routine?
(Answers: frequently vs. sometimes, seldom
or never)
Population of the practice location
> 100.000 Reference
20.000–99.000 0.93 (0.50–1.73)
5.000–20.000 1.95 (1.07–3.56)
< 5.000 1.08 (0.53–2.19)
Age (in years)
> 60 Reference
56–60 3.22 (1.42–7.31)
51–55 1.79 (0.76–4.18)
45–50 2.99 (1.34–6.65)
40–44 3.17 (1.30–7.72)
< 40 3.97(1.32–11.91)
Do you use the strategy of delayed
antibiotic prescription?
(Answer: very often/often vs. sometimes/
seldom/unknown strategy)
Population of the practice location
> 100.000 Reference
20.000–99.000 0.49 (0.26–0.91)
5.000–20.000 0.39 (0.21–0.75)
< 5.000 0.57 (0.28–1.17)
Indications for me prescribing antibiotics are …
…acute infection with yellow/green sputum
(rather yes vs. rather not, to a certain degree)
Medical specialization
General Medicine Reference
Internal Medicine 2.36 (1.08–5.17)
No specialization 9.07 (0.85–96.99)
Work experience
0–7 years Reference
Table 2 Results of the multivariable analysis (Continued)
Questions Odds Ratio (95% CI)
8–14 years 1.85 (0.90–3.80)
14–25 years 3.33 (1.69–6.58)
> 25 years 6.54 (3.22–13.30)
CI confidence interval, MDRO multidrug resistant organism
Note. Predictors in the multivariable analysis are shown in Table 1
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progression of the infection was difficult to predict. Only
29.4% (74/340) answered that they often or very often
apply delayed prescribing, a strategy for dealing with un-
complicated acute respiratory infections in which the
use of an antibiotic is recommended to a patient only if
the symptoms persist or worsen or further test results
come in. 337 of the 340 participants (99.1%) were famil-
iar with this strategy.
Thirty-six percent (123/340; Fig. 1) responded that an
acute infection with yellow or green sputum is an indica-
tion for antibiotic prescription. GPs with more work
experience tended to use the color of sputum more
often as an indicator for an antimicrobial therapy (>
25 years of working experience vs. < 7 years; OR 6.54,
95% CI 3.22–13.30; P < 0.001).
Awareness of antimicrobial resistance and
communication aspects
Sixty-eight percent (285/340) of the family doctors
stated that they often or very often discuss the subject
drug-resistant organisms with patients who have an in-
fection that requires antibiotic therapy; 80.6% (274/340)
discuss the subject if the patient does not need antibi-
otics (Fig. 2). In this survey the main reasons for not
discussing this topic were a lack of time (50.6%) and the
assumption that their patients were not interested in this
subject (42.9%; Fig. 3).
Discussion
We performed a questionnaire-based survey of general
practitioners on patterns of antimicrobial use, patient
communication, awareness of rising drug-resistance in
primary care and the source of information acquisition.
This study demonstrates different specific barriers to
rational antibiotic therapy in primary care. First of all, it
should be acknowledged that the awareness of anti-
microbial resistance among general practitioners has
risen during the past few years. In 2007/2008 the Robert
Koch Institute distributed a written survey to GPs in
Germany. In that survey, 35.8% of the GPs expressed the
belief that their prescribing behavior influences drug-re-
sistance in their area [31, 32]. We repeated this question
in our survey and 70.2% (239/340) of the participants
agreed that their behavior affected drug resistance. This
rising awareness might be influenced by international,
European and national reports and campaigns that deal
with this topic [33–36].
Second, the reliability of sputum color as an indicator
for an antimicrobial therapy was overestimated by a ma-
jority of the participants. Our investigation found that
over one third (36.2%) of the participants use the color
as an indication, another third are uncertain (35.9%) and
only 25.9% (88/340) of general practitioners do not use
sputum color when deciding whether to start antibiotic
therapy. Other studies support these findings [28, 37]. In
selected diagnoses, especially in chronic lung diseases,
the sputum color has a value for antimicrobial therapy
decision [38, 39]. Nevertheless, the reproducibility of the
evaluation of sputum color has poor inter-rater reliabil-
ity [40] and is not recommended in the case of an acute
respiratory tract infection [41].
Fig. 1 Diagnostic value of the sputum color. Answers on the
statement: “For me, the indications for an antibiotic prescription are
the green colour of the sputum (in the context of an acute
respiratory tract infection)” (n = 333)
Fig. 2 AMR communication. Answers on the Question: “Do you
discuss the topic of antimicrobial resistance (AMR) with patients with
an acute infection?” (n = 338)
Fig. 3 AMR missing communication (multiple selection). “Reasons
not to talk about antibiotic resistance (AMR).” (n = 338)
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In order to work in Germany as a family doctor a
5 year medical specialization in either internal medi-
cine or in general medicine is required. Alternatives
to practicing as a general practitioner exist, however
rarely. 84.7% (288/340) of the participants have a
specialization in general medicine, 10% (34/340) in in-
ternal medicine (Table 1). GPs with a specialization in
internal medicine were more likely to prescribe an
antibiotic based on the color of the sputum than were
GPs with a specialization in general medicine (OR 2.
36, 95%CI 1.08–5.17; P = 0.03). One explanation for
why GPs with a specialization in internal medicine
were 2.4 times more likely than participants who
specialized in general or family medicine to prescribe
antibiotics based on sputum color is that the recom-
mendation not to use the color of the sputum as an
indicator is very prominent in the guidelines of the
German Society of General Practice and Family
Medicine (Deutsche Gesellschaft für Allgemeinmedi-
zin und Familienmedizin, DEGAM) [42]. To address
the diagnostic uncertainty between a severe acute
bronchitis and a starting pneumonia the biomarker as
point of care tests are promising [43]. However the
reimbursement for GPs in Germany is difficult. An al-
ternative strategy to reduce antibiotic use is delayed
prescription [44, 45]. The strategy is well known
among the participants (337/340) while only one third
(74/340) apply it “often” or “very often”. There is
room for improvement in the implementation of the
strategy in daily outpatient care, considering the fact
that only 21.8% (74/340) use this strategy often and
only 7.6% (26/340) very often.
Third, some authors emphasize that when GPs feel
pressure from their patients, they are more likely to
prescribe antibiotics [46–49]. Accordingly, about one
third of the participants (102/340) prescribe antibi-
otics when a patient requests some or when the
patient wants to return to work quickly (97/340).
However, in this survey general practitioners who felt
pressure from their patients remained a minority. Un-
fortunately, we did not conduct patient interviews to
evaluate patient requests for antibiotic therapy. Never-
theless, supported by other authors, we believe that
GPs place too much importance on patient requests
for antimicrobial therapy [50, 51] .
Focusing on aspects of communication, it is striking
that a lack of time was the main reason not to talk about
antimicrobial resistance (172/340). Some authors de-
scribe an antibiotic prescription as an effective means to
avoid confrontation and to terminate a consultation
[28]. Accordingly, the majority of antibiotic prescriptions
are inappropriate in ambulatory care [7]. Patient leaflets
could be used for this purpose but there is a lack of
established German leaflets for acute respiratory tract
infections. There are leaflets of the Center for Disease
Control and Prevention (CDC) available in English [52].
This study has certain limitations. All answers are self-
reported. Furthermore, as a questionnaire study, this
survey contains the risk that respondents will give
answers believed to be socially acceptable. The represen-
tativeness of the study is limited because the sample was
not selected purely randomly, but was instead contacted
on the basis of existing address data (self-selection bias).
On the other hand, the GPs contacted represent about
one third of all GPs working in the region. The response
rate is comparable to other studies conducted in
Germany [30, 53].
Another limitation is that the questionnaire was only
distributed in eastern Germany.
This is due to the fact that this survey was performed
in preparation for an intervention campaign that started
in August 2016 and focused on rational antibiotic use by
GPs in eastern Germany. Looking at the socio-
demographic parameters of the participants, it is notice-
able that they were about 2 years younger (51.9 vs. 54.3)
than the GPs average in Germany and were more likely
to be female (62.4% vs 41.0 female GPs). There were
only minor differences in the type of workplace [54].
Conclusion
When deciding on a therapy, the diagnostic value of
sputum color is often overestimated. Delayed prescrip-
tion is well known but only partially applied. Neverthe-
less, there is a strong awareness of antimicrobial
resistance among the participating GPs. Furthermore,
time restrictions disturb doctor-patient communication.
Implementation of change to a more rational antibiotic
use should address such specific barriers as precondi-
tions to having a sustainable effect. This survey shows
clear targets for further approaches to reduce the preva-
lence of drug-resistant organisms.
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